Introduction: The association of family cases of epilepsy and intellectual disability in women was reported in 1971. In 2008, the role of pathogenic variants of the PCDH19 gene in some families were identified. The disease presents with febrile seizure clusters, intellectual disability, and autistic features. Most cases are due to de novo variants, however, there are some inherited cases, with an atypical way of X-linked transmission.
Objective: To report the case of a patient with epilepsy carrier of a pathogenic variant of the PCDH19 gene, reviewing the natural history of this condition and the available evidence for its management.
Clinical Case: Female patient, with normal history of pregnancy and perinatal period. At 6 months, while febrile, she presented focal motor seizure clusters that repeated at 14, 18, 21 months and 3 years old, always associated with fever, even presenting status epilepticus. She is on therapy with topiramate and valproic acid, achieving 13 seizure-free years. The analysis of the SCN1A gene showed no abnormalities and the study of the PCDH19 gene revealed a de novo heterozygous pathogenic variant. The patient evolved with intellectual disability and severe behavioral disorders that require mental health team support.
Conclusions: PCDH19 pathogenic variants have varied phenotypic expression. The genetic diagnosis should be guided with the clinical features. Long-term psychiatric morbidity can be disabling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.32641/rchped.vi91i5.1490 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Chromosome X-wide common variant association study in autism spectrum disorder.
Am J Hum Genet
January 2025
The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada; McLaughlin Centre and Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address:
Autism spectrum disorder (ASD) displays a notable male bias in prevalence. Research into rare (<0.1) genetic variants on the X chromosome has implicated over 20 genes in ASD pathogenesis, such as MECP2, DDX3X, and DMD.
View Article and Find Full Text PDFA Case Report of Parental Germline Mosaicism in the Gene of Two Iranian Siblings.
Basic Clin Neurosci
July 2024
Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article Synopsis
- DEE9 is a developmental and epileptic encephalopathy caused by mutations in a specific gene, leading to early-onset seizures, intellectual disabilities, and behavioral issues, particularly affecting certain females and rare male cases.
- The study reported two sisters with DEE9 who have a specific heterozygous mutation, following genetic testing methods like whole-exome sequencing and Sanger sequencing.
- The findings highlight the recognition of germline mosaicism for this gene, underlining the need for genetic counseling and considering prenatal diagnosis in families affected by X-linked or autosomal dominant disorders.
Triplication of the Gene as a Novel Disease Mechanism Leading to Epileptic Encephalopathy Resembling Loss-of-Function Pathogenic Variants.
Genes (Basel)
October 2024
Translational Research Group in Genetics, La Fe Health Research Institute, 46026 Valencia, Spain.
Background/objectives: Developmental and epileptic encephalopathy 9 (DEE9) (MIM #300088) affects heterozygous females and males with somatic pathogenic variants, while male carriers with hemizygous pathogenic variants are clinically unaffected. There are hundreds of pathogenic single nucleotide variants in the gene reported in the literature, which lead to the loss of function of the PCDH19 protein. To date, no phenotypes associated with overexpression or copy number gains have been described in this gene.
View Article and Find Full Text PDFTherapeutic implications of etiology-specific diagnosis of early-onset developmental and epileptic encephalopathies (EO-DEEs): A nationwide Turkish cohort study.
Seizure
December 2024
Medipol University Faculty of Medicine, Department of Pediatrics, Division of Pediatric Neurology, Istanbul, Turkiye.
Objective: To evaluate the etiology-specific diagnosis of early-onset developmental epileptic encephalopathies (EO-DEEs) in a nationwide Turkish cohort to determine the implications for therapeutic management.
Methods: The cohort comprised 1450 patients who underwent EO-DEE. The utility of genetic testing was assessed with respect to the initial phases of next generation sequencing (NGS) (2005-2013) and the current NGS era (2014-2022).
Dravet-like syndrome with PCDH19 mutations in Taiwan - A multicenter study.
Pediatr Neonatol
August 2024
Division of Pediatric Neurology, Chang Gung Children's Hospital and Chang Gung Memorial Hospital, Taoyuan, Taiwan; Chang Gung University College of Medicine, Taoyuan, Taiwan. Electronic address:
Article Synopsis
- Protocadherin-19 (PCDH19) epilepsy is a rare condition primarily affecting females, characterized by early-onset seizures and developmental delays due to mutations in the PCDH19 gene on the X chromosome.
- A study of fifteen female patients in Taiwan revealed that seizures typically began between 4 months and 2 years of age, often occurring in clusters, with varying levels of intellectual disability among the patients.
- The research identified distinct mutations in the PCDH19 gene and highlighted the use of multiple antiseizure medications, with some patients achieving seizure freedom, but no specific medication class proven most effective for this syndrome.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!